The research and application of cardiovascular path in congenital heart disease

Transcription

1 Chinese Journal of Tissue Engineering Research April 8, 2017 Vol.21, No ( ). [J] (10): DOI: /j.issn ORCID: () 28 PubMed Medline cardiac tissue engineeringpericardium patchstem cellcongential heart diseasecongenital heart conditionschd 32 ((2016)5614 ) ((2014)59 ) The research and application of cardiovascular path in congenital heart disease Mi Fang 1, Yu Li-mei 1, 2, Zhao Chun-hua 3 ( 1 Guizhou Provincial Key Laboratory of Cell Engineering, 2 Biological Treatment Talent Base of Guizhou Province, Affiliated Hospital of Zunyi Medical University, Zunyi , Guizhou Province, China; 3 Beijing Key Laboratory of Stem Cell New Drug Research and Clinical Translation, Center for Tissue Engineering Research, Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences & School of Basic Medicine of Peking Union Medical College, Beijing , China) :R318 :A : (2017) Mi Fang, Studying for master s degree, Guizhou Provincial Key Laboratory of Cell Engineering, Affiliated Hospital of Zunyi Medical University, Zunyi , Guizhou Province, China Corresponding author: Yu Li-mei, M.D., Professor, Master s supervisor, Guizhou Provincial Key Laboratory of Cell Engineering, Affiliated Hospital of Zunyi Medical University, Zunyi , Guizhou Province, China; Biological Treatment Talent Base of Guizhou Province, Affiliated Hospital of Zunyi Medical University, Zunyi , Guizhou Province, China ISSN CN /R CODEN: ZLKHAH 1635

2 . Corresponding author: Zhao Chun-hua, M.D., Professor, Doctoral supervisor, Beijing Key Laboratory of Stem Cell New Drug Research and Clinical Translation, Center for Tissue Engineering Research, Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences & School of Basic Medicine of Peking Union Medical College, Beijing , China Abstract BACKGROUND: Tissue-engineered cardiovascular patch plays a decisive role in the surgical treatment of congenital heart diseases. Its construction strategies are rich and flexible. This kind of patch has a wide range of application in basic and clinical research. OBJECTIVE: To review some progresses in the surgical application of cardiovascular patch in congenital heart disease and the methods to construct the tissue-engineered cardiovascular patch. METHODS: PubMed, Medline, CNKI and ClinicalTrials.gov were searched by computer for articles related to classification, design, basic and clinical research of tissue-engineered cardiovascular patch were published between January 2001 and December The keywords were cardiac tissue engineering, pericardium patch, stem cell, congenital heart disease, congenital heart conditions, CHD in English and cardiac patch, vascular patch, cardiovascular patch, congenital heart disease in Chinese. Finally, 32 articles were included in result analysis RESULTS AND CONCLUSION: With the development of human stem cell biology, materials science and testing technology, the tissue-engineered cardiovascular material is expected to achieve standardization and industrialization management. However, subsequent problems need to be solved, for example, the specific implementation of a three-dimensional vascular design strategy, the loading proportion of a variety of seed cells, pre-clinical quality control and industrial management standards, as well as the close international cooperation that can promote the overall healthy development of the industry. Subject headings: Heart Diseases; Biocompatible Materials; Tissue Engineering Funding: the Innovation Talent Team Project for Basic and Clinical Research on Bone Marrow and Amniotic Stem Cells in Guizhou Province, No. (2016)5614; Construction Project of Stem Cell and Regeneration Medical Engineering Research Center of Zunyi City, No. (2014)59 Cite this article: Mi F, Yu LM, Zhao CH. The research and application of cardiovascular path in congenital heart disease. Zhongguo Zuzhi Gongcheng Yanjiu. 2017;21(10): Introduction 3D 1Data and methods (Medline)(ClinicalTrials. gov) PubMedMedline cardiac tissue engineering, pericardium patch, stem cell, congential heart disease, congenital heart conditions, CHD cardiac tissue engineering OR pericardium patch AND stem cell PubMed SCI () 1636 P.O. Box 10002, Shenyang

3 cardiac tissue engineering OR pericardium patch AND stem cell PubMed / 2Results 2.1 (1%) [1] 0.7%0.8% [2] (50%) [3] 20% [4] 1964Dotter 1997 Amplatzer (atrial septal defectasd) (patent ductus arteriosuspda) (ventricular septal defectvsd) PubMed Medline cardiac tissue engineering pericardium patch stem cell congenital heart disease congenital heart conditions CHD % [5] [6] Guo [7] 2%6% 39% 27%40% ISSN CN /R CODEN: ZLKHAH 1637

4 . [8] () () [9-11] [12] [13] 2.2 [14-16] [17] [14] [16] 1638 [14] [18] [19] [20] [21-22] [14] / [23] [24] [25] [26] Syedain [25] 50% Weber [27] P.O. Box 10002, Shenyang

5 [14,28-29] [30] [31] 40%60% [4] (SDSTriton X-100) Boccardo [32] ( ) 5%10% 3Discussion 20 (RISMA ) References [1] Hamilton BE, Hoyert DL, Martin JA, et al. Annual summary of vital statistics: Pediatrics. 2013;131(3): [2],. [J]., 2004, 42(11): [3] Steeds RP, Oakley D. Predicting late sudden death from ventricular arrhythmia in adults following surgical repair of tetralogy of Fallot. QJM. 2004;97(1):7-13. ISSN CN /R CODEN: ZLKHAH 1639

6 . [4] O'Brien MF, Harrocks S, Clarke A, et al. How to do safe sternal reentry and the risk factors of redo cardiac surgery: a 21-year review with zero major cardiac injury. J Card Surg. 2002;17(1):4-13. [5] Dobell AR, Jain AK. Catastrophic hemorrhage during redo sternotomy. Ann Thorac Surg. 1984;37(4): [6] Hong JH, Choe JW, Kwon GY, et al. The effects of barrier materials on reduction of pericardial adhesion formation in rabbits: a comparative study of a hyaluronan-based solution and a temperature sensitive poloxamer solution/gel material. J Surg Res. 2011;166(2): [7] Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60(22): [8] Stevens KR, Kreutziger KL, Dupras SK, et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A. 2009; 106(39): [9] Park SO, Han J, Minn KW, et al. Prevention of capsular contracture with Guardix-SG( ) after silicone implant insertion. Aesthetic Plast Surg. 2013;37(3): [10] Kang H, Chung YS, Kim SW, et al. Effect of Temperature-Sensitive Poloxamer Solution/Gel Material on Pericardial Adhesion Prevention: Supine Rabbit Model Study Mimicking Cardiac Surgery. PLoS One. 2015;10(11): e [11] Walther T, Rastan A, Dähnert I, et al. A novel adhesion barrier facilitates reoperations in complex congenital cardiac surgery. J Thorac Cardiovasc Surg. 2005;129(2): [12] Khalpey Z, Marsh KM, Ferng A, et al. First in man: amniotic patch reduces postoperative inflammation. Am J Med. 2015; 128(1):e5-6. [13] Heydrick S, Roberts E, Kim J, et al. Pediatric cardiovascular grafts: historical perspective and future directions. Curr Opin Biotechnol. 2016;40: [14] Ruzmetov M, Shah JJ, Geiss DM, et al. Decellularized versus standard cryopreserved valve allografts for right ventricular outflow tract reconstruction: a single-institution comparison. J Thorac Cardiovasc Surg. 2012;143(3): [15] Ozawa H, Miyagawa S, Fukushima S, et al. Extracellar Matrix Preserving Decellulerized Heart Valve Maintain Valvular Function in vivo by Enhancing Functional Cell Recellularization. Circulation. 2014; 130:A [16] Phelps EA, García AJ. Engineering more than a cell: vascularization strategies in tissue engineering. Curr Opin Biotechnol. 2010;21(5): [17] Radisic M, Park H, Shing H, et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A. 2004;101(52): [18] Takawale A, Sakamuri SS, Kassiri Z. Extracellular matrix communication and turnover in cardiac physiology and pathology. Compr Physiol. 2015;5(2): [19] Park JS, Cha SJ, Kim BG, et al. An assessment of the effects of a hyaluronan-based solution on reduction of postsurgical adhesion formation in rats: a comparative study of hyaluronan-based solution and two film barriers. J Surg Res. 2011;168(1): [20] Sakai T, Li RK, Weisel RD, et al. The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. J Thorac Cardiovasc Surg. 2001;121(5): [21] Griffith CK, Miller C, Sainson RC, et al. Diffusion limits of an in vitro thick prevascularized tissue.tissue Eng. 2005;11(1-2): [22] Lv S, Dudek DM, Cao Y, et al. Designed biomaterials to mimic the mechanical properties of muscles. Nature. 2010;465 (7294): [23] Stoppato M, Stevens HY, Carletti E, et al. Effects of silk fibroin fiber incorporation on mechanical properties, endothelial cell colonization and vascularization of PDLLA scaffolds. Biomaterials. 2013n;34(19): [24] Frescaline G, Bouderlique T, Mansoor L, et al. Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo. Tissue Eng Part A. 2013;19(13-14): [25] Syedain ZH, Bradee AR, Kren S, et al. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng Part A. 2013;19(5-6): [26] Hirt MN, Hansen A, Eschenhagen T. Cardiac tissue engineering: state of the art. Circ Res. 2014;114(2): [27] Weber B, Dijkman PE, Scherman J, et al. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials. 2013;34(30): [28] Gaustad KG, Boquest AC, Anderson BE, et al. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun. 2004; 314(2): [29] Chiavegato A, Bollini S, Pozzobon M, et al. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol. 2007;42(4): [30] Syedain ZH, Meier LA, Bjork JW, et al. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials. 2011;32(3): [31] McAllister TN, Maruszewski M, Garrido SA, et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet. 2009;373(9673): [32] Boccardo S, Gaudiello E, Melly L, et al. Engineered mesenchymal cell-based patches as controlled VEGF delivery systems to induce extrinsic angiogenesis. Acta Biomater. 2016;42: P.O. Box 10002, Shenyang